Panelists discuss how the pathophysiology of pulmonary arterial hypertension involves complex mechanisms across multiple genetic and treatment pathways, with over 20 identified genes and four major ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, and welcome to this podcast series. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular ...

High blood pressure, also known as hypertension, affects over 1.5 billion people around the world. It is one of the top ...

Positive high-level results from the Bax24 Phase III trial showed baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in ambulatory 24-hour average systolic ...

Pulmonary arterial hypertension (PAH), characterized by elevated blood pressure in the pulmonary artery, is a rare condition that disproportionately affects women. Over the last decade, a greater ...

Merck said that a phase-three study of its pulmonary arterial hypertension treatment met its primary endpoints. On Monday, the pharmaceutical company said it has received positive topline results from ...

I've done many clinical trials in this area, and I do some primary investigative work in the genomics and risk stratification for this disease. Again, I'm very happy to be here to talk about the ...